Ziang Wan
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
SNHG26 Promotes Colorectal Cancer Progression via CDKN2A-Dependent Regulation of Cuproptosis and CD8+ T Cell-Mediated Immunity.
Journal: Journal of cellular and molecular medicine
Published: April 05, 2025
EEPD1 is identified as a predictor of prognosis and immune microenvironment through pan-cancer analysis and related to progression of colorectal cancer.
Journal: Heliyon
Published: August 16, 2023
Herbal medicine and its impact on the gut microbiota in colorectal cancer.
Journal: Frontiers in cellular and infection microbiology
Published: November 11, 2022
Loss of exosomal miR-200b-3p from hypoxia cancer-associated fibroblasts promotes tumorigenesis and reduces sensitivity to 5-Flourouracil in colorectal cancer via upregulation of ZEB1 and E2F3.
Journal: Cancer gene therapy
Published: August 08, 2022
Loss of exosomal micro-RNA-200b-3p from hypoxia cancer-associated fibroblasts reduces sensitivity to 5-flourouracil in colorectal cancer through targeting high-mobility group box 3.
Journal: Frontiers in oncology
Published: April 14, 2022
HMGB3 is a Potential Therapeutic Target by Affecting the Migration and Proliferation of Colorectal Cancer.
Journal: Frontiers in cell and developmental biology
Published: March 07, 2022
Polypectomy During Both Insertion and Withdrawal Phase Versus During Withdrawal Phase Only: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Journal: Journal of laparoendoscopic & advanced surgical techniques. Part A
Published: August 25, 2020
MEIS2 promotes cell migration and invasion in colorectal cancer.
Journal: Oncology reports
Published: October 09, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026